Skip to main content

Bellevue Group AG

SEC CIK
0001674546
Latest filing
Aug 14, 2026

ONC holding history

BeOne Medicines Ltd. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ONC overviewAll 13F holders of ONCFull Q2 2026 holdings

Shares (Q2 2026)
10,474
Value
$2.98M
% of portfolio
0.1%
Quarters held
20
Since Q1 2021
Holdings of ONC by Bellevue Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,474$2.98M0.1%+6,662+174.8%AddedHolders
Q1 20263,812$1.13M<0.1%+1,922+101.7%AddedHolders
Q4 20251,890$574.2K<0.1%−31,907−94.4%ReducedHolders
Q3 202533,797$11.5M0.2%−4,901−12.7%ReducedHolders
Q2 202538,698$9.37M0.2%+3,369+9.5%AddedHolders
Q1 202535,329$9.62M0.2%+1,100+3.2%AddedHolders
Q4 202434,229$6.32M0.1%−24,500−41.7%ReducedHolders
Q3 202458,729$13.2M0.2%+33,100+129.2%AddedHolders
Q2 202425,629$3.66M0.1%+700+2.8%AddedHolders
Q1 202424,929$3.90M0.1%−3,671−12.8%ReducedHolders
Q4 202328,600$5.21M0.1%−24,600−46.2%ReducedHolders
Q3 202353,200$9.50M0.2%+43,000+421.6%AddedHolders
Q2 202310,200$1.82M<0.1%−48,035−82.5%ReducedHolders
Q1 202358,235$12.6M0.2%+23,735+68.8%AddedHolders
Q4 202234,500$7.71M0.1%+27,500+392.9%AddedHolders
Q3 20227,000$940.0K<0.1%+7,000NewHolders
Q1 20220$00.0%−23,000−100.0%Sold outHolders
Q4 202123,000$6.23M0.1%00.0%UnchangedHolders
Q3 202123,000$8.35M0.1%−61,300−72.7%ReducedHolders
Q2 202184,300$28.9M0.3%+24,600+41.2%AddedHolders
Q1 202159,700$20.8M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.